Literature DB >> 3092271

Effects of D-Met2, Pro5-enkephalinamide on pain tolerance and some cognitive functions in man.

J I Székely, K Török, I Karczag, J Tolna, M Till.   

Abstract

The effects of D-Met2, Pro5-enkephalinamide (EA) on pain tolerance and some cognitive functions have been examined in healthy male volunteers. Dihydrocodeine (DC) was used as reference substance. Applying the submaximum effort tourniquet technique EA (10 mg SC) was found to elevate the pain threshold similarly to DC (20 mg SC). Neither DC nor EA impaired the performance in the symbol cancellation test, which quantitates the intensity of attention. In this assay rather a slight improvement was detected. in addition the short-term memory performance (Wechsler test) was also improved by EA and DC. No alteration was seen in the word fluency test, an indicator of long-term (semantic) memory. The data show that EA not only improves pain tolerance but some of its mental effects are similar to those of a classical morphine congener DC.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092271     DOI: 10.1007/bf02412112

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  EEG and clinical profile of a synthetic analogue of methionine-enkephalin - FK 33-824.

Authors:  E Krebs; J Roubicek
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1979-01

2.  A superactive antinociceptive pentapeptide, (D-Met2, Pro5)-enkephalinamide.

Authors:  S Bajusz; A Z Rónai; J I Székely; L Gráf; Z Dunai-Kovács; I Berzétei
Journal:  FEBS Lett       Date:  1977-04-01       Impact factor: 4.124

3.  Synthetic enkephalin analogue in treatment of schizophrenia.

Authors:  A Jørgensen; R Fog; B Veilis
Journal:  Lancet       Date:  1979-04-28       Impact factor: 79.321

4.  Metkephamid, a systemically active analog of methionine enkephalin with potent opioid alpha-receptor activity.

Authors:  R C Frederickson; E L Smithwick; R Shuman; K G Bemis
Journal:  Science       Date:  1981-02-06       Impact factor: 47.728

5.  Epidural met-enkephalin (FK 33-824). A dose-effect study.

Authors:  H B Andersen; B C Jørgensen; A Engquist
Journal:  Acta Anaesthesiol Scand       Date:  1982-02       Impact factor: 2.105

6.  Entry of opioid peptides into the central nervous system.

Authors:  S I Rapoport; W A Klee; K D Pettigrew; K Ohno
Journal:  Science       Date:  1980-01-04       Impact factor: 47.728

7.  Beta-endorphin: pharmacologic and behavioral activity in cats after low intravenous doses.

Authors:  D H Catlin; R George; C H Li
Journal:  Life Sci       Date:  1978-11-20       Impact factor: 5.037

8.  Involvement of alpha-adrenergic mechanisms in growth hormone release induced by opioid peptides in conscious rats.

Authors:  H Katakami; Y Kato; N Matsushita; S Hiroto; A Shimatsu; H Imura
Journal:  Neuroendocrinology       Date:  1981-09       Impact factor: 4.914

9.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.

Authors:  R Guillemin; T Vargo; J Rossier; S Minick; N Ling; C Rivier; W Vale; F Bloom
Journal:  Science       Date:  1977-09-30       Impact factor: 47.728

10.  Profound analgesic effects of beta-endorphin in man.

Authors:  T Oyama; T Jin; R Yamaya; N Ling; R Guillemin
Journal:  Lancet       Date:  1980-01-19       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.